Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 8.30K | 98.10K | |||
| Gross Profit | -8.30K | -98.10K | |||
| SG&A Expenses | 579.30K | 5.34M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 587.60K | 5.67M | |||
| Operating Income | -587.60K | -5.67M | |||
| Income Before Tax | -587.60K | -5.68M | |||
| Income Tax Expenses | -- | 2.30K | |||
| Earnings from Continuing Operations | -587.60K | -5.68M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -587.60K | -5.68M | |||
| EBIT | -587.60K | -5.67M | |||
| EBITDA | -580.20K | -5.66M | |||
| EPS Basic | -30.67 | -383.55 | |||
| Normalized Basic EPS | -19.17 | -239.62 | |||
| EPS Diluted | -30.67 | -383.55 | |||
| Normalized Diluted EPS | -19.17 | -239.62 | |||
| Average Basic Shares Outstanding | 19.20K | 14.80K | |||
| Average Diluted Shares Outstanding | 19.20K | 14.80K | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||